| Name | Title | Contact Details |
|---|
Audible Difference is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since opening its doors in 1957, Southeast Health has provided for the changing healthcare needs of the growing communities it serves which includes about 600,000 residents neighboring communities and counties of Southeast Alabama, Southwest Georgia and the Florida Panhandle. Our progress represents the culmination of distinguished service by dedicated board members, physicians, employees and volunteers, and a supportive community. It takes more than technology and a modern facility to treat people. It takes a team of dedicated, well-trained professionals to continually deliver quality healthcare. Employing about 2,500, Southeast Health is recognized as one of the largest employers in the region and is proud of its reputation of providing a positive and responsive work environment. Southeast Health`s medical staff consists of more than 225 active members and just over 400 total members either board certified or board prepared in specialties representing virtually every area of medicine. Through innovation and sustained performance, Southeast Health, a 420-bed regional referral center, has achieved the reputation of providing the best diagnostic, clinical, surgical and patient care services available in the region.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
NovaSom is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wellbridge is a Greenwood Vlg, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.